Jean‐Pierre Salles

Centre National de la Recherche Scientifique — France

Biochemistry, Genetics and Molecular Biology · Life Sciences

42h-index6.6kcitations224works3.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Genetic Syndromes and Imprinting(23), Connective tissue disorders research(21), Protein Tyrosine Phosphatases(21), Growth Hormone and Insulin-like Growth Factors(20), Parathyroid Disorders and Treatments(19)

Publications222 total

Determinants of adverse event occurrence in children with short stature born small for gestational age treated with growth hormone
Frontiers in Endocrinology·2025Open Access
Safety and immunogenicity of PPV-06, an active anti-IL-6 immunotherapy targeting low-grade inflammation against knee osteoarthritis: a randomized, double-blind, placebo-controlled, clinical phase 1 study
Nature Communications·2025· 1 citedOpen Access
Health-related quality of life in French pediatric patients with X-linked hypophosphatemia: real-world data from the International XLH Registry
JBMR Plus·2025· 1 citedOpen Access
Effects of Semaglutide With or Without Concomitant Mineralocorticoid Receptor Antagonist Use in Participants With Type 2 Diabetes and Chronic Kidney Disease: A FLOW Trial Prespecified Secondary Analysis
Diabetes Care·2025· 7 citedOpen Access
DESIGN OF THE ANTI-IL-6 ACTIVE IMMUNOTHERAPY IN INFLAMMATORY KNEE OSTEOARTHRITIS: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER TRIAL
Osteoarthritis and Cartilage·2025
Cognitive Stability Among Plasma p-tau 181 Negative Individuals: A 5-year Analysis of the Multidomain Alzheimer Prevention Trial Study
The Journals of Gerontology Series A·2025
Early oxytocin treatment in infants with Prader–Willi syndrome is safe and is associated with better endocrine, metabolic and behavioral outcomes
Orphanet Journal of Rare Diseases·2025· 6 citedOpen Access
O13: Oral infigratinib for children with achondroplasia: Month 18 results from the PROPEL 2 study
Genetics in Medicine Open·2025Open Access
Oral Infigratinib Therapy in Children with Achondroplasia
New England Journal of Medicine·2024· 19 cited
From Classical to Alternative Pathways of 2-Arachidonoylglycerol Synthesis: AlterAGs at the Crossroad of Endocannabinoid and Lysophospholipid Signaling
Molecules·2024· 3 citedOpen Access
Orofacial Features, Oral Health-Related Quality of Life, and Exposure to Bullying in Osteogenesis Imperfecta: A Cross-Sectional Study
Children·2024Open Access
LBA0011 SAFETY AND IMMUNOGENICITY OF AN ACTIVE ANTI-IL-6 IMMUNOTHERAPY IN A PHASE 1 CLINICAL TRIAL IN KNEE OSTEOARTHRITIS PATIENTS
Annals of the Rheumatic Diseases·2024
SAFETY, IMMUNE RESPONSE AND PRELIMINARY EFFICACY OF PPV-06 ACTIVE IMMUNOTHERAPY, A VACCINE FOR INFLAMMATORY KNEE OSTEOARTHRITIS: A PHASE 1, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, DOSE ESCALATION STUDY
Osteoarthritis and Cartilage·2024Open Access
Differential DNA methylation in iPSC-derived dopaminergic neurons: a step forward on the role of SNORD116 microdeletion in the pathophysiology of addictive behavior in Prader-Willi syndrome
Molecular Psychiatry·2024· 1 citedOpen Access
Plasma p-tau181 as an outcome and predictor of multidomain intervention effects: a secondary analysis of a randomised, controlled, dementia prevention trial
The Lancet Healthy Longevity·2024· 10 citedOpen Access
Longitudinal Associations Between ATPase Inhibitory Factor 1, Growth Differentiation Factor-15, and Nutritional Status in Older Adults From the MAPT Study
The Journals of Gerontology Series A·2023· 6 citedOpen Access
THU165 PROPEL, PROPEL 2 And PROPEL OLE Studies Of Infigratinib In Children With Achondroplasia: Design And Status Of 3 Ongoing Trials
Journal of the Endocrine Society·2023Open Access
THU181 Evaluation Of Bone Mineral Density In A Cohort Of Children With ACH Participating In The PROPEL 2 Study Of Infigratinib
Journal of the Endocrine Society·2023Open Access
OR27-03 Oral Infigratinib Treatment Is Well Tolerated And Significantly Increases Height Velocity In Children With Achondroplasia: Month 6 Results From The PROPEL 2 Dose-finding Study
Journal of the Endocrine Society·2023· 2 citedOpen Access
Adult height improved over decades in patients with X-linked hypophosphatemia: a cohort study
European Journal of Endocrinology·2023· 6 cited
page 1 of 12Next →

Frequent Co-authors

M. Tauber(14), Armelle Yart(12), Thomas Édouard(11), Bertrand Perret(9), Patrick Raynal(9), Isabelle Gennero(9), F. Conte-Auriol(7), Marie Dance(6), Alexandra Montagner(6), Catherine Molinas(5), Gwénaëlle Diene(5), Sara Laurencin‐Dalicieux(4), Fabienne Briand‐Mésange(4), Catherine Arnaud(4), Hugues Chap(4), Mylène Tajan(4), Philippe Valet(4), G Brunel(3), Josette Fauvel(3), Toshiyuki Araki(3)